According to reports, C.R. Bard Inc., has agreed to settle a one of its Avaulta vaginal-mesh implant lawsuits, which allegedly caused severe urinary problems. This case was set for trial this month in New Jersey. Bard agreed to pay an undisclosed sum to resolve Melanie Virgil’s claims that Bard’s Avaulta…
The U.S. District Judge presiding over the federal transvaginal mesh litigation has chosen four Boston Scientific cases that will be considered for early bellwether trials, scheduled to start in 2014. Litigation Continues to Grow There are more than 22,500 federal lawsuits involving vaginal mesh pelvic repair systems manufactured by different…
Recently, Bard settled the second federal Avaulta bellwether trial over its alleged defective transvaginal mesh devices. The settlement was announced by U.S. District Judge Goodwin, who is supervising the transvaginal mesh product liability lawsuits in Charleston, W.Va. As previously noted, in the first Bard Avaulta bellwether trial, the jury awarded…
Last week, a federal jury in West Virginia awarded $2 million in damages in a Bard Avaulta vaginal mesh defective product liability claim. The verdict included punitive damages to punish CR Bard Inc., the manufacturer for selling a defective product that has been linked to severe internal injuries. This is…
U.S. District Judge Joseph Goodwin presiding over the first federal Bard Mesh trial has declared a mistrial. This trial involved complications associated with Bard Avaulta mesh. On the second day of trial, a gynecological expert mentioned that the Bard Avaulta mesh has been removed from the market. In pre-trial rulings,…